Fáilte chuig an Institiúid um Leigheas Athghiniúnach
Welcome to the Regenerative Medicine Institute (REMEDI®)

Dr. Alan Colman

Adjunct Professor of Fundamental Stem Cell Biology
0065 64070150

Adult stem cells, Differentiation, Drug discovery, Customized stem cells

Researcher in

Research Project Area: 

A major focus of his own work comprises neurodegenerative and premature aging diseases. His research involves developing induced pluripotent stem cell (iPS) based laboratory models of human central nervous system disease lines to investigate the pathophysiology of human congenital disease. Currently the lab focuses on diseases of premature ageing, central nervous system monogenicdisease, and heart compliants such as dilated cardiomyopathy.

Positions Held: 

June 2007 - Present  Principal Investigator, A*STAR Institute of Medical Biology & Executive Director, Singapore Stem Cell Consortium (SSCC).

June 2005 - June 2007  Chief Executive Officer, ES International, Singapore.

February 2005 - June 2005  Chief Scientific Officer, ES International, Singapore.

1987 - February 2002   Research Director, PPL Therapeutics, Edinburgh, UK.

Selected Publications: 

Zhang J, Lian Q, Zhu G, Zhou F, Sui L, Tan C, Mutalif RA, Navasankari R, Zhang Y, Tse HF, Stewart CL, Colman A. A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects.  Cell Stem Cell. 2011 Jan 7;8(1):31-45. Epub 2010 Dec 23.

Taylor PL, Barker RA, Blume KG, Cattaneo E, Colman A, Deng H, Edgar H, Fox IJ, Gerstle C, Goldstein LS, High KA, Lyall A, Parkman R, Pitossi FJ, Prentice ED, Rooke HM, Sipp DA, Srivastava A, Stayn S, Steinberg GK, Wagers AJ, Weissman IL. Patients beware: commercialized stem cell treatments on the web.Cell Stem Cell. 2010 Jul 2;7(1):43-9. Epub 2010 Jun 17.

Colman A and Dreesen O (2009) Pluripotent Stem Cells and Disease Modeling Cell Stem Cell 5 244-247. 

Colman A and Dreesen O (2009) Induced pluripotent stem cells and the stability of the differentiated state EMBO Reports 10 714-721. 

Wu D, Raymond J, Wu M, Chatterji S, Ren Q, Graham JE, Bryant DA, Robb F, Colman A, Tallon LJ, Badger JH, Madupu R, Ward NL, Eisen JA. (2009) Complete genome sequence of the aerobic CO-oxidizing thermophile Thermomicrobium roseum. PLoS One. 4(1): e4207.

Xu XQ, Zweigerdt R, Soo SY, Ngoh ZX, Tham SC, Wang ST, Graichen R, Davidson B, Colman A, Sun W.(2008) Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy. 2008;10(4):376-89.

Xu XQ, Graichen R, Soo SY, Balakrishnan T, Bte Rahmat SN, Sieh S, Tham SC, Freund C, Moore J, Mummery C, Colman A, Zweigerdt R, Davidson BP. (2008) Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation. 76:958–970.

Graichen, R. Xu, X. Braam, S. R. Balakrishnan, T. Norfiza, S. Sieh, S. Soo, S. Y. Tham, S. C. Mummery, C. Colman, A. Zweigerdt, R. Davidson, B. P. (2008) Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK Differentiation 76 357

12. Phillips, B. W. Hentze, H. Rust, W. L. Chen, Q. P. Chipperfield, H. Tan, E. K. Abraham, S. Sadasivam, A. Soong, P. L. Wang, S. T. Lim, R. Sun, W. Colman, A. Dunn, N. R. (2007) Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage. Stem Cells and Development 16 561-578.

Crook, J. M. Peura, T. T. Kravets, L. Bosman, A. G. Buzzard, J. J. Horne, R. Hentze, H. Dunn, N. R. Zweigerdt, R. Chua, F. Upshall, A. Colman, A. (2007) The Generation of Six Clinical-Grade Human Embryonic Stem Cell Lines Cell Stem Cell 1 490-494.

Buzzard JJ, Gough NM, Crook JM, Colman A (2004) Karyotype of human ES cells during extended culture. Nat Biotechnol. 22:381-2.

Colman A (2004) Making new beta cells from stem cells. Seminars in Cell and Developmental Biology 15(3):337-45.

Yifan Dai, Todd D. Vaught, Jeremy Boone, Shu-Hung Chen, Carol J. Phelps, Suyapa Ball , Jeff A. Monahan, Peter M. Jobst , Ashley E. Lamborn, Jamie L. Cowell-Lucero, Kevin D.Wells, Kenneth J. McCreath, Alan Colman , Irina A. Polejaeva and David L. Ayares Targeted Disruption of the 1,3-galactosyltransferase Gene in Cloned Pigs (2002) Nature Biotechnology 20 251-255.

Polejaeva, I. Chen S-H, Vaught T, Page R, Mullins J, Ball S, Boone J, Walker S, Dai Y, Ayares, D Colman A. and Campbell K. (2000) Cloned pigs produced by nuclear transfer from adult somatic cells Nature 407 86-90.

. McCreath K, Howcroft J, Campbell K, Colman A, Schneike A and Kind A (2000) Production of gene-targeted sheep by nuclear transfer from cultured somatic cells. Nature 405 1066-69.

Shiels P, Kind A, Campbell K, Wilmut I, Waddington, Colman A, and Schneike A (1999) Analysis of telomere length in Dolly, a Sheep derived by nuclear transfer Cloning 1 119-125.

Shiels P, Kind A Campbell, K, Waddington D, Wilmut I, Colman A, Schneike A (1999) Analysis of telomere lengths in cloned sheep Nature 399 316-317.

Gurdon J B and Colman A (1999) The Future of Cloning. Nature 402 743-746.

Ashworth D, Bishop,M, Campbell,K, Colman A, Kind A, Schnieke, A,Blott, S Griffin, H , Haley C, McWhir J, Wilmut I (1998) DNA microsatellite analysis of Dolly. Nature 394 329.

Schneike A, Kind A, Ritchie, W, Mycock,K, Scott, A, Ritchie, M, Wilmut I, Colman A and Campbell K (1997) Human Factor IX transgenic sheep produced by transfer of nuclei from transfected fetal oocytes. Science 278 2130-2133.

Professional and Personal Interests: 

Professional Memberships

European Molecular Biology Organisation

Search PubMed for Papers by Dr. Alan Colman >>